INHIBITION OF LIPOPOLYSACCHARIDE-INDUCED INTERFERON REGULATORY FACTOR 3 ACTIVATION AND PROTECTION FROM SEPTIC SHOCK BY HYDROXYSTILBENES
- 1 May 2004
- journal article
- basic science-aspects
- Published by Wolters Kluwer Health in Shock
- Vol. 21 (5) , 470-475
- https://doi.org/10.1097/00024382-200405000-00012
Abstract
Interferon regulatory factor 3 (IRF3) mediates the transcriptional induction of interferon-stimulated genes (ISGs) in response to viral and bacterial infections. Here we show that the hydroxystilbene piceatannol inhibits the LPS-mediated activation of IRF3 and subsequent ISG induction. Consequently, piceatannol blocks the LPS-induced up-regulation of critical mediators of the inflammatory response such as interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α), intercellular adhesion molecule 1 (ICAM-1), and macrophage chemoattractant protein (MCP-1). Furthermore, the LPS-mediated induction of tissue factor (TF), a cell surface protein responsible for initiating the coagulation cascade, is also inhibited by piceatannol. The effectiveness of piceatannol in blocking both the inflammatory response and the coagulation pathway is evidenced by its ability to confer protection against LPS-induced septic shock in a murine model. Thus, IRF3 appears to be a promising target for pharmacologic intervention in the prevention or treatment of septic shock syndrome.Keywords
This publication has 30 references indexed in Scilit:
- Clinical Trial Design and Outcomes in Patients with Severe SepsisShock, 2003
- Interaction Between the Innate and Adaptive Immune Systems is Required to Survive Sepsis and Control Inflammation After InjuryShock, 2003
- Essential role of IRF-3 in lipopolysaccharide-induced interferon-β gene expression and endotoxin shockBiochemical and Biophysical Research Communications, 2003
- A META-ANALYSIS OF CONTROLLED TRIALS OF ANTICOAGULANT THERAPIES IN PATIENTS WITH SEPSISShock, 2003
- The protein C pathwayCritical Care Medicine, 2000
- Distinct Mechanisms of STAT Phosphorylation via the Interferon-α/β ReceptorJournal of Biological Chemistry, 2000
- The Jak-STAT pathwayMolecular Immunology, 2000
- HOW CELLS RESPOND TO INTERFERONSAnnual Review of Biochemistry, 1998
- TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT PathwayAnnual Review of Biochemistry, 1995
- Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elementsCell, 1988